Podcast: Inside the Private Markets with Nick Fusco, Founder & CEO of PM Insights
by Kristi Marvin on 2025-02-25 at 7:44am

This week, in a special edition of the SPACInsider Podcast, we focus on the private markets with PM Insights founder and CEO Nick Fusco.

Nick weighs in with his thoughts on the major trends shaping private market valuations today and how the market has evolved since the pandemic years.

Plus, how difficult is it to gain reliable data on private funding rounds and what lessons can be learned for SPACs making their own valuation decisions while on the hunt for a deal?

PM Insights is a secondary market pricing and analytics provider focusing on private market company stocks.

Give it a listen.


spotify-iconApple-podcasts-icon-v2

 

 

 


 

Recent Posts
by Nicholas Alan Clayton on 2025-04-29 at 7:03pm

Berto Acquisition Corp. (NASDAQ:TACOU) announced the pricing of its upsized $261 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “TACOU”, Wednesday, April 30, 2025. The new SPAC aims to conduct a broad search for a target but will have a particular interest in artificial intelligence, wellness, longevity,...

by Nicholas Alan Clayton on 2025-04-29 at 6:20pm

Lakeshore Acquisition III Corp. (NASDAQ:LCCCU) announced the pricing of its $60 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “LCCCU”, Wednesday, April 30, 2025. The new SPAC aims to conduct a broad search for a target with a team that has previously closed business combinations in the...

by Kristi Marvin on 2025-04-29 at 3:35pm

Churchill Capital Corp X (NASDAQ:CCCXU) has filed for a $300 million SPAC with a broad search focus, to add to the portfolio of Churchill deals. Five Churchill deals have closed (I, II, III, IV, and AltC), while V, VI and VII liquidated in the SPAC downturn. However, keep in mind that the Churchill team still...

by Nicholas Alan Clayton on 2025-04-29 at 11:50am

Black Hawk Acquisition Corp (NASDAQ:BKHA) has entered into a definitive agreement to combine with biotech firm Vesicor Therapeutics at a pre-money equity value of $70 million. San Gabriel, California-based Vesicor is developing treatments utilizing extracellular vesicles as both a therapy themselves and as a delivery system for other medicines. The combined company is expected to...

by Nicholas Alan Clayton on 2025-04-29 at 8:11am

At the SPAC of Dawn SPAC activity has continued to heat up as the market now has a new business combination to digest alongside two new SPACs making their debut on the Nasdaq later today. Three more new SPACs have filed their initial S-1s to eventually join them. That makes 29 SPAC IPOs and 49...

logo

Copyright © 2025 SPACInsider, Inc. All Rights Reserved